Related Experiment Video
Updated: Nov 3, 2025

07:47
Isolation of Lung Retinoid-Containing Cells by Cell Sorting
Published on: April 11, 2025
485
S-nitrosylation of surfactant protein-D controls inflammatory function
Chang-Jiang Guo1, Elena N Atochina-Vasserman, Elena Abramova
1Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Plos Biology
|November 15, 2008
Summary
Nitric oxide (NO) S-nitrosylation modifies pulmonary surfactant protein D (SP-D) structure, altering its inflammatory signaling. This post-translational modification switches SP-D
Area of Science:
- Pulmonary immunology
- Innate immunity
- Post-translational modifications
Background:
- Pulmonary collectins, surfactant proteins A and D (SP-A, SP-D), regulate lung innate immunity.
- SP-D exhibits dual pro- and anti-inflammatory roles, but the underlying mechanisms are unclear.
- SP-D's unique multimeric structure, stabilized by N-terminal cysteines, differs from other collectins.
Purpose of the Study:
- To investigate the role of S-nitrosylation in regulating SP-D's structure and function.
- To elucidate the molecular mechanisms by which SP-D's inflammatory signaling is controlled.
Main Methods:
- In vitro and in vivo studies using a rodent acute lung injury model.
- Analysis of SP-D structure, including multimerization and cysteine status.
- Assessment of SP-D's effect on macrophage chemoattraction and p38 MAPK phosphorylation.
Main Results:
- SP-D cysteines are targets for S-nitrosylation by nitric oxide (NO).
- S-nitrosylation disrupts SP-D multimers, favoring trimeric forms (SNO-SP-D).
- SNO-SP-D, but not native SP-D, attracts macrophages and induces p38 MAPK phosphorylation via calreticulin/CD91.
Conclusions:
- Nitric oxide-mediated S-nitrosylation is a key regulator of SP-D's inflammatory signaling.
- Post-translational modification alters SP-D's quaternary structure, switching its immune function.
- This study provides novel insights into NO's role in innate immunity and protein regulation by S-nitrosylation.
Related Concept Videos
Regulation of Nuclear Protein Sorting
2.8K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.8K
Nitric Oxide Signaling Pathway
5.5K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.5K
Breathing
61.8K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
61.8K
Antiasthma Drugs: Leukotriene Modifiers
1.4K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.4K
NF-κB-dependent Signaling Pathway
8.0K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.0K

